Chiara Cremolini

20.5k total citations · 7 hit papers
335 papers, 7.6k citations indexed

About

Chiara Cremolini is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Chiara Cremolini has authored 335 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 295 papers in Oncology, 155 papers in Pulmonary and Respiratory Medicine and 94 papers in Cancer Research. Recurrent topics in Chiara Cremolini's work include Colorectal Cancer Treatments and Studies (264 papers), Gastric Cancer Management and Outcomes (90 papers) and Cancer Treatment and Pharmacology (88 papers). Chiara Cremolini is often cited by papers focused on Colorectal Cancer Treatments and Studies (264 papers), Gastric Cancer Management and Outcomes (90 papers) and Cancer Treatment and Pharmacology (88 papers). Chiara Cremolini collaborates with scholars based in Italy, United States and Germany. Chiara Cremolini's co-authors include Alfredo Falcone, Fotios Loupakis, Gianluca Masi, Lisa Salvatore, Carlotta Antoniotti, Giuseppe Tonini, Sara Lonardi, Gabriella Fontanini, Luca Boni and Alberto Zaniboni and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Nature Genetics.

In The Last Decade

Chiara Cremolini

310 papers receiving 7.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study

2015 733 citations Chiara Cremolini, Fotios Loupakis et al. profile →
Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer

2014 720 citations Fotios Loupakis, Chiara Cremolini et al. profile →
Primary Tumor Location as a Prognostic Factor in Metastatic Colorectal Cancer

2015 340 citations Fotios Loupakis, Dongyun Yang et al. profile →
Quantitative evidence for early metastatic seeding in colorectal cancer

2019 289 citations Chiara Cremolini, Alfredo Falcone et al. profile →
Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer

2023 183 citations Julien Taı̈eb, Marwan Fakih et al. profile →
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C

2023 163 citations Marwan Fakih, Lisa Salvatore et al. profile →
Colorectal cancer

2024 126 citations Erika Ruíz‐García, Chiara Cremolini et al. profile →

Peers

Countries citing papers authored by Chiara Cremolini

Since Specialization

Citations

This map shows the geographic impact of Chiara Cremolini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Cremolini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Cremolini more than expected).

Fields of papers citing papers by Chiara Cremolini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiara Cremolini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Cremolini. The network helps show where Chiara Cremolini may publish in the future.

Co-authorship network of co-authors of Chiara Cremolini

This figure shows the co-authorship network connecting the top 25 collaborators of Chiara Cremolini. A scholar is included among the top collaborators of Chiara Cremolini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara Cremolini. Chiara Cremolini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Overall Survival Analysis of the Phase III CodeBreaK 300 Study of Sotorasib Plus Panitumumab Versus Investigator's Choice in Chemorefractory KRAS G12C Colorectal Cancer 2025 ·Journal of Clinical Oncology ·Filippo Pietrantonio, Lisa Salvatore, Taito Esaki, Dominik Paul Modest, D. Páez López-Bravo, Julien Taı̈eb, Michalis V. Karamouzis, Erika Ruíz‐García, Tae Won Kim, Yasutoshi Kuboki, Fausto Meriggi, David Cunningham, Kun‐Huei Yeh, Emily Chan, Joseph Chao, Qui Tran, Chiara Cremolini, Marwan Fakih	7
2	The relative dose intensity of first-line FOLFOXIRI and FOLFOX/FOLFIRI both in combination with bevacizumab affects prognosis of metastatic colorectal cancer patients: A pooled analysis of TRIBE and TRIBE2 studies 2025 ·European Journal of Cancer ·Roberto Moretto, Daniele Rossini, (unknown), Carlotta Antoniotti, Rossana Intini, Veronica Conca, (unknown), (unknown), Lisa Salvatore, Marco Maria Germani, Francesca Bergamo, Alessandro Passardi, (unknown), Emiliano Tamburini, (unknown), (unknown), Gianluca Masi, Filippo Pietrantonio, Sara Lonardi, Chiara Cremolini	0
3	Detecting BRAF mutations in colorectal cancer in clinical practice: An Italian experts' position paper 2024 ·Critical Reviews in Oncology/Hematology ·(unknown), Valentina Angerilli, Rossana Intini, Francesca Bergamo, Chiara Cremolini, Federica Grillo, Elena Guerini‐Rocco, Tiziana Pia Latiano, Erika Martinelli, Nicola Normanno, Fabio Pagni, Paola Parente, Alessandro Pastorino, Filippo Pietrantonio, Lisa Salvatore, Sara Lonardi, Matteo Fassan	3
4	Predicting early recurrence after resection of initially unresectable colorectal liver metastases: the role of baseline and pre-surgery clinical, radiological and molecular factors in a real-life multicentre experience 2024 ·ESMO Open ·Roberto Moretto, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Lucio Urbani, Sara Lonardi, (unknown), (unknown), (unknown), F. D’Amico, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Chiara Cremolini	1
5	Predicting Benefit From FOLFOXIRI Plus Bevacizumab in Patients With Metastatic Colorectal Cancer 2024 ·JCO Clinical Cancer Informatics ·Marinde J. G. Bond, Maarten van Smeden, Koen Degeling, Chiara Cremolini, Hans‐Joachim Schmoll, Carlotta Antoniotti, Sara Lonardi, Sabina Murgioni, Daniele Rossini, Stefan Ibach, Miriam Koopman, Rutger‐Jan Swijnenburg, Cornelis J.A. Punt, Anne M. May, Johannes J.M. Kwakman	2
6	Rechallenge with anti-EGFR therapy to extend the continuum of care in patients with metastatic colorectal cancer 2023 ·Frontiers in Oncology ·Chiara Cremolini, Clara Montagut, Philippe Ronga, Filippo Venturini, Kensei Yamaguchi, Sebastian Stintzing, Alberto Sobrero	13
7	Pretreatment Plasma Circulating Tumor DNA RAS/BRAF Mutational Status in Refractory Metastatic Colorectal Cancer Patients Who Are Candidates for Anti-EGFR Rechallenge Therapy: A Pooled Analysis of the CAVE and VELO Clinical Trials 2023 ·Cancers ·Davide Ciardiello, Stefania Napolitano, Vincenzo Famiglietti, Lucia Esposito, Vincenzo De Falco, (unknown), Antonio Avallone, Evaristo Maiello, Filippo Pietrantonio, Chiara Cremolini, Maria Giulia Zampino, Nicola Fazio, Teresa Troiani, Erika Martinelli, Fortunato Ciardiello, Giulia Martini	6
8	Exploring the Outcome of Disappearance or Small Remnants of Colorectal Liver Metastases during First-Line Chemotherapy on Hepatobiliary Contrast-Enhanced and Diffusion-Weighted MR Imaging 2023 ·Cancers ·Piero Boraschi, Roberto Moretto, Francescamaria Donati, Beatrice Borelli, (unknown), (unknown), Alessandra Boccaccino, (unknown), (unknown), S Signori, Gianluca Masi, Chiara Cremolini, Lucio Urbani	3
9	Fluoropyrimidine-induced hand-foot syndrome and cardiotoxicity: recommendations for the use of the oral fluoropyrimidine S-1 in metastatic colorectal cancer 2023 ·ESMO Open ·Cornelis J.A. Punt, Volker Heinemann, Tim Maughan, Chiara Cremolini, Eric Van Cutsem, Ray McDermott, (unknown), Thierry André, Pia Österlund, Arco J. Teske, Per Pfeiffer	4
10	Association of immune-related adverse events with the outcomes of immune checkpoint inhibitors in patients with dMMR/MSI-H metastatic colorectal cancer 2023 ·Journal for ImmunoTherapy of Cancer ·(unknown), Francesco Barretta, Francesca Corti, Sara Lonardi, Monica Niger, María Elena Elez, Marwan Fakih, Priya Jayachandran, (unknown), Massimiliano Salati, Elisabetta Fenocchio, Lisa Salvatore, Chiara Cremolini, Javier Ros, Margherita Ambrosini, (unknown), Rossana Intini, Michael J. Overman, Rosalba Miceli, Filippo Pietrantonio	13
11	Reinduction of an Anti-EGFR-based First-line Regimen in Patients with RAS Wild-type Metastatic Colorectal Cancer Enrolled in the Valentino Study 2022 ·The Oncologist ·Giovanni Fucà, Alessandra Raimondi, Michele Prisciandaro, Sara Lonardi, Chiara Cremolini, Margherita Ratti, Matteo Clavarezza, Roberto Murialdo, Andrea Sartore‐Bianchi, Valeria Smiroldo, Rosa Berenato, Patrizia Racca, Francesca Bergamo, Salvatore Corallo, Maria Di Bartolomeo, Filippo de Braud, Federica Morano, Filippo Pietrantonio	5
12	Safety and Activity of PolyPEPI1018 Combined with Maintenance Therapy in Metastatic Colorectal Cancer: an Open-Label, Multicenter, Phase Ib Study 2022 ·Clinical Cancer Research ·Joleen M. Hubbard, Enikő R. Tőke, Roberto Moretto, Rondell P. Graham, Hagop Youssoufian, (unknown), (unknown), (unknown), Jessica L. Mitchell, (unknown), József Tóth, Chiara Cremolini	23
13	RNA-Binding Protein Polymorphisms as Novel Biomarkers to Predict Outcomes of Metastatic Colorectal Cancer: A Meta-analysis from TRIBE, FIRE-3, and MAVERICC 2021 ·Molecular Cancer Therapeutics ·Hiroyuki Arai, Shu Cao, Francesca Battaglin, (unknown), Natsuko Kawanishi, Ryuma Tokunaga, Fotios Loupakis, Sebastian Stintzing, Shivani Soni, Wu Zhang, Christoph Mancao, Bodour Salhia, Shannon M. Mumenthaler, Chiara Cremolini, Volker Heinemann, Alfredo Falcone, Joshua Millstein, Heinz‐Josef Lenz	0
14	Applicazioni cliniche di bevacizumab nel trattamento del tumore del colon-retto e dell’ovaio 2021 ·Recenti Progressi in Medicina ·Romano Danesi, Chiara Cremolini, Francesca Ciccarone, Domenica Lorusso	1
15	Clinical Validation of a Machine-learning–derived Signature Predictive of Outcomes from First-line Oxaliplatin-based Chemotherapy in Advanced Colorectal Cancer 2020 ·Clinical Cancer Research ·Jim Abraham, Daniel Magee, Chiara Cremolini, Carlotta Antoniotti, (unknown), Joanne Xiu, Phillip Stafford, Donald A. Berry, Matthew J. Oberley, Anthony F. Shields, John L. Marshall, Mohamed E. Salem, Alfredo Falcone, Axel Grothey, Michael J. Hall, Alan P. Venook, Heinz‐Josef Lenz, (unknown), W. Michael Korn, David Spetzler	35
16	Prognostic and Predictive Biomarkers in Patients with Metastatic Colorectal Cancer Receiving Regorafenib 2020 ·Molecular Cancer Therapeutics ·Yingmiao Liu, Jing Lyu, Kirsten B. Burdett, Alexander B. Sibley, Ace J. Hatch, Mark D. Starr, John C. Brady, (unknown), Federica Marmorino, Daniele Rossini, Richard M. Goldberg, Alfredo Falcone, Chiara Cremolini, Kouros Owzar, Anastasia Ivanova, Dominic T. Moore, Michael S. Lee, Hanna K. Sanoff, Federico Innocenti, Andrew B. Nixon	15
17	Early modifications of circulating microRNAs levels in metastatic colorectal cancer patients treated with regorafenib 2019 ·The Pharmacogenomics Journal ·Marta Schirripa, Beatrice Borelli, Romina D’Aurizio, Simone Lubrano, Chiara Cremolini, (unknown), Carlotta Antoniotti, Federica Marmorino, Alessandra Anna Prete, Sabina Murgioni, Francesca Bergamo, Vittorina Zagonel, Andrea Tuccoli, Andrea Marranci, Milena Rizzo, Lorena Tedeschi, Letizia Magnoni, Alfredo Falcone, Fotios Loupakis, Laura Poliseno	5
18	Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients 2017 ·Clinical Cancer Research ·Carmine Carbone, Geny Piro, Francesca Simionato, Francesca Ligorio, Chiara Cremolini, Fotios Loupakis, Greta Alì, Daniele Rossini, Valeria Merz, Raffaela Santoro, Camilla Zecchetto, Marco Zanotto, Federica Di Nicolantonio, Alberto Bardelli, Gabriella Fontanini, Giampaolo Tortora, Davide Melisi	41
19	A Polymorphism within the Vitamin D Transporter Gene Predicts Outcome in Metastatic Colorectal Cancer Patients Treated with FOLFIRI/Bevacizumab or FOLFIRI/Cetuximab 2017 ·Clinical Cancer Research ·Martin D. Berger, Sebastian Stintzing, Volker Heinemann, Shu Cao, Dongyun Yang, Yu Sunakawa, Satoshi Matsusaka, Yan Ning, Satoshi Okazaki, Yuji Miyamoto, Mitsukuni Suenaga, Marta Schirripa, Diana L. Hanna, Shivani Soni, Alberto Puccini, Wu Zhang, Chiara Cremolini, Alfredo Falcone, Fotios Loupakis, Heinz‐Josef Lenz	21
20	Polymorphisms in Genes Involved in EGFR Turnover Are Predictive for Cetuximab Efficacy in Colorectal Cancer 2015 ·Molecular Cancer Therapeutics ·Sebastian Stintzing, Wu Zhang, Volker Heinemann, Daniel Neureiter, Ralf Kemmerling, Thomas Kirchner, Andreas Jung, Matthias Folwaczny, Dongyun Yang, Yan Ning, Ana Sebio, Stefan Stremitzer, Yu Sunakawa, Satoshi Matsusaka, Shinichi Yamauchi, Fotios Loupakis, Chiara Cremolini, Alfredo Falcone, Heinz‐Josef Lenz	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact